Asia · Prensa financiera · The Economic Times

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

Publicado por The Economic Times · India hace 4 h

Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong…

Leer el artículo completo en The Economic Times Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (economictimes.indiatimes.com)

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

También te puede interesar

China’s Communist Party Fills 10 Central Committee Vacancies

Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Uniqlo shakes up China strategy with focus on store profitability

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

Compartir

También te puede interesar

China’s Communist Party Fills 10 Central Committee Vacancies

Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Uniqlo shakes up China strategy with focus on store profitability